168 related articles for article (PubMed ID: 28300085)
1. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.
Grasso S; Chapelle J; Salemme V; Aramu S; Russo I; Vitale N; Verdun di Cantogno L; Dallaglio K; Castellano I; Amici A; Centonze G; Sharma N; Lunardi S; Cabodi S; Cavallo F; Lamolinara A; Stramucci L; Moiso E; Provero P; Albini A; Sapino A; Staaf J; Di Fiore PP; Bertalot G; Pece S; Tosoni D; Confalonieri S; Iezzi M; Di Stefano P; Turco E; Defilippi P
Nat Commun; 2017 Mar; 8():14797. PubMed ID: 28300085
[TBL] [Abstract][Full Text] [Related]
2. The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness.
Salemme V; Angelini C; Chapelle J; Centonze G; Natalini D; Morellato A; Taverna D; Turco E; Ala U; Defilippi P
Cell Mol Life Sci; 2021 Feb; 78(4):1355-1367. PubMed ID: 33079227
[TBL] [Abstract][Full Text] [Related]
3. The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma.
Grasso S; Cangelosi D; Chapelle J; Alzona M; Centonze G; Lamolinara A; Salemme V; Angelini C; Morellato A; Saglietto A; Bianchi FT; Cabodi S; Salaroglio IC; Fusella F; Ognibene M; Iezzi M; Pezzolo A; Poli V; Di Cunto F; Eva A; Riganti C; Varesio L; Turco E; Defilippi P
Cell Death Differ; 2020 Feb; 27(2):790-807. PubMed ID: 31285546
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the Shared and Context-Dependent Pathways Mediated by the p140Cap Adaptor Protein in Cancer and in Neurons.
Chapelle J; Sorokina O; McLean C; Salemme V; Alfieri A; Angelini C; Morellato A; Adrait A; Menna E; Matteoli M; Couté Y; Ala U; Turco E; Defilippi P; Armstrong JD
Front Cell Dev Biol; 2019; 7():222. PubMed ID: 31681758
[TBL] [Abstract][Full Text] [Related]
5. p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation.
Damiano L; Di Stefano P; Camacho Leal MP; Barba M; Mainiero F; Cabodi S; Tordella L; Sapino A; Castellano I; Canel M; Frame M; Turco E; Defilippi P
Oncogene; 2010 Jun; 29(25):3677-90. PubMed ID: 20453886
[TBL] [Abstract][Full Text] [Related]
6. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
8. p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.
Damiano L; Le Dévédec SE; Di Stefano P; Repetto D; Lalai R; Truong H; Xiong JL; Danen EH; Yan K; Verbeek FJ; De Luca E; Attanasio F; Buccione R; Turco E; van de Water B; Defilippi P
Oncogene; 2012 Feb; 31(5):624-33. PubMed ID: 21725361
[TBL] [Abstract][Full Text] [Related]
9. Author Correction: The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.
Grasso S; Chapelle J; Salemme V; Aramu S; Russo I; Vitale N; di Cantogno LV; Dallaglio K; Castellano I; Amici A; Centonze G; Sharma N; Lunardi S; Cabodi S; Cavallo F; Lamolinara A; Stramucci L; Moiso E; Provero P; Albini A; Sapino A; Staaf J; Di Fiore PP; Bertalot G; Pece S; Tosoni D; Confalonieri S; Iezzi M; Di Stefano P; Turco E; Defilippi P
Nat Commun; 2018 Mar; 9():16203. PubMed ID: 29600801
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
Schade B; Lesurf R; Sanguin-Gendreau V; Bui T; Deblois G; O'Toole SA; Millar EK; Zardawi SJ; Lopez-Knowles E; Sutherland RL; Giguère V; Kahn M; Hallett M; Muller WJ
Cancer Res; 2013 Jul; 73(14):4474-87. PubMed ID: 23720052
[TBL] [Abstract][Full Text] [Related]
11. High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers.
Desai K; Nair MG; Prabhu JS; Vinod A; Korlimarla A; Rajarajan S; Aiyappa R; Kaluve RS; Alexander A; Hari PS; Mukherjee G; Kumar RV; Manjunath S; Correa M; Srinath BS; Patil S; Prasad MS; Gopinath KS; Rao RN; Violette SM; Weinreb PH; Sridhar TS
Cancer Med; 2016 Aug; 5(8):2000-11. PubMed ID: 27184932
[TBL] [Abstract][Full Text] [Related]
12. SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue.
Kennedy S; Clynes M; Doolan P; Mehta JP; Rani S; Crown J; O'Driscoll L
Br J Cancer; 2008 May; 98(10):1641-5. PubMed ID: 18475297
[TBL] [Abstract][Full Text] [Related]
13. Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion.
Xue B; Krishnamurthy K; Allred DC; Muthuswamy SK
Nat Cell Biol; 2013 Feb; 15(2):189-200. PubMed ID: 23263278
[TBL] [Abstract][Full Text] [Related]
14. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity.
Di Stefano P; Damiano L; Cabodi S; Aramu S; Tordella L; Praduroux A; Piva R; Cavallo F; Forni G; Silengo L; Tarone G; Turco E; Defilippi P
EMBO J; 2007 Jun; 26(12):2843-55. PubMed ID: 17525734
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis.
Chapelle J; Baudino A; Torelli F; Savino A; Morellato A; Angelini C; Salemme V; Centonze G; Natalini D; Gai M; Poli V; Kähne T; Turco E; Defilippi P
Am J Cancer Res; 2020; 10(12):4308-4324. PubMed ID: 33415001
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
[TBL] [Abstract][Full Text] [Related]
17. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
18. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
[TBL] [Abstract][Full Text] [Related]
19. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression.
Floris A; Luo J; Frank J; Zhou J; Orrù S; Biancolella M; Pucci S; Orlandi A; Campagna P; Balzano A; Ramani K; Tomasi ML
J Exp Clin Cancer Res; 2019 Jan; 38(1):4. PubMed ID: 30611309
[TBL] [Abstract][Full Text] [Related]
20. Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer.
Wolfson E; Goldenberg M; Solomon S; Frishberg A; Pinkas-Kramarski R
Oncotarget; 2016 Oct; 7(40):65320-65334. PubMed ID: 27542246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
